Myopodin methylation is a prognostic biomarker and predicts...

  • Main
  • 2016 / 9
  • Myopodin methylation is a prognostic biomarker and predicts...
Tumor Biology 2016 / 9

Myopodin methylation is a prognostic biomarker and predicts antiangiogenic response in advanced kidney cancer

Pompas-Veganzones, N., Sandonis, V., Perez-Lanzac, Alberto, Beltran, M., Beardo, P., Juárez, A., Vazquez, F., Cozar, J. M., Alvarez-Ossorio, J. L., Sanchez-Carbayo, Marta
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Tumor Biology
DOI:
10.1007/s13277-016-5267-8
Date:
September, 2016
File:
PDF, 950 KB
english, 2016
Conversion to is in progress
Conversion to is failed